Brief: Solvonis Therapeutics Announces £1 Mln Subscription To Accelerate AI Drug Discovery
July 11 (Reuters) - Solvonis Therapeutics PLC SVNS.L: SOLVONIS THERAPEUTIC - £1M SUBSCRIPTION TO ACCELERATE AI DRUG DISCOVERY Source text: ID:nRSK6425Qa Further company coverage: SVNS.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solvonis Therapeutics
See all newsBrief: Solvonis Therapeutics Plans IND Submission For Phase 2B Trial Of SVN-2 In U.S.
Solvonis Therapeutic - Announces Positive Bridging Data Supporting
Solvonis Therapeutic - Notice of Annual General Meeting
RCS - Solvonis Therapeutic - CSO Speaks at National Research Meeting
Solvonis Therapeutic - Final Results